EMA approves Moderna vaccine for 12-17 age group

Health

Published: 2021-07-23 21:16

Last Updated: 2021-09-25 19:22


EMA approves Moderna vaccine for 12-17 age group
EMA approves Moderna vaccine for 12-17 age group

Friday, the European Medicines Agency (EMA), the European Union's (EU) official health regulator approved the use of the Moderna COVID-19 vaccine for people aged 12 to 17 years, becoming the second vaccine allowed for use in adolescents in the 27 European Union countries.

The EMA said in a statement that the concerned committee recommended the use of the vaccine for the aforementioned age group, noting that it will be administered in two doses separated by four weeks.